• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体功能障碍和血清乳酸作为 MS 进展和残疾的生物标志物及其与影像学发现的相关性。

Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings.

机构信息

Neurology Department, Faculty of Medicine, Mansoura University, Mansoura, Dakahlia, Egypt.

Diagnostic Radiology Department, Faculty of Medicine, Kafrelsheikh University, Kafr Ash Shaykh, Egypt.

出版信息

Neurol Res. 2021 Jul;43(7):582-590. doi: 10.1080/01616412.2021.1893567. Epub 2021 Mar 4.

DOI:10.1080/01616412.2021.1893567
PMID:33657991
Abstract

: To study the serum lactate level in MS and to explore its correlation with the progression and disability in multiple sclerosis (MS), and the important role of mitochondrial dysfunction in the pathogenesis of MS.: This case-control study included 80 participants, involved 50 MS patients and 30 normal healthy controls. Detailed history taking, complete neurological examination, and clinical evaluation of the disability using the Expanded Disability Status Scale (EDSS) were done for all patients. Level of serum lactate was measured in both groups and was correlated with EDSS, MS subtypes, MRI brain, and MRS findings.: Serum lactate in MS patients was about three and half times higher than serum lactate levels of healthy controls (22.87 ± 5.92 mg/dl versus 6.39 ± 0.9 6.39 ± 0.91, p < 0.001). Importantly, serum lactate values were increased in MS cases with a progressive course compared with MS cases with RR course. Also, there were linearly correlations linking serum lactate levels and the duration of MS (r = 0.342, P = 0.015), relapses numbers (r = 0.335, P = 0.022), and EDSS (r = 0.483, P < 0.001). Also, there were strong positive correlations between serum lactate and Lipid/Lactate (r = 0.461, P = 0.001), periventricular lesion (r = 0.453, P = 0.005), and moderate positive correlations between serum lactate and juxtacortical lesion (r = 0.351, P = 0.02), and infratentorial lesion (r = 0.355, P = 0.02).: Measurement of serum lactate may be helpful in MS and this supports the hypothesis of the critical role of mitochondrial dysfunction and axonal damage in MS.: ClinicalTrials.gov ID: NCT04210960.

摘要

研究多发性硬化症(MS)患者的血清乳酸水平,探讨其与 MS 进展和残疾的相关性,以及线粒体功能障碍在 MS 发病机制中的重要作用。

本病例对照研究纳入了 80 名参与者,包括 50 名 MS 患者和 30 名正常健康对照。对所有患者进行详细的病史询问、全面的神经系统检查以及使用扩展残疾状况量表(EDSS)进行残疾临床评估。测量两组患者的血清乳酸水平,并与 EDSS、MS 亚型、MRI 脑和 MRS 结果进行相关性分析。

MS 患者的血清乳酸水平约为健康对照组的 3.5 倍(22.87±5.92 mg/dl 与 6.39±0.91,p<0.001)。重要的是,与 RR 病程的 MS 病例相比,进展性病程的 MS 病例中血清乳酸值升高。此外,血清乳酸水平与 MS 病程时间(r=0.342,P=0.015)、复发次数(r=0.335,P=0.022)和 EDSS(r=0.483,P<0.001)呈线性相关。此外,血清乳酸与脂质/乳酸(r=0.461,P=0.001)、脑室周围病变(r=0.453,P=0.005)之间存在强烈正相关,与皮质下病变(r=0.351,P=0.02)和幕下病变(r=0.355,P=0.02)之间存在中度正相关。

血清乳酸的测量可能有助于 MS 的诊断,这支持了线粒体功能障碍和轴突损伤在 MS 中起关键作用的假说。

临床试验注册号

NCT04210960。

相似文献

1
Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings.线粒体功能障碍和血清乳酸作为 MS 进展和残疾的生物标志物及其与影像学发现的相关性。
Neurol Res. 2021 Jul;43(7):582-590. doi: 10.1080/01616412.2021.1893567. Epub 2021 Mar 4.
2
Serum lactate as a novel potential biomarker in multiple sclerosis.血清乳酸作为多发性硬化症中一种新的潜在生物标志物。
Biochim Biophys Acta. 2014 Jul;1842(7):1137-43. doi: 10.1016/j.bbadis.2014.04.005. Epub 2014 Apr 13.
3
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.多发性硬化症(MS)队列中的神经胶质和神经轴突生物标志物
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:113-121.
4
Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.血清能量代谢紊乱化合物与多发性硬化症的残疾、病程和神经影像学有关。
Mol Neurobiol. 2017 Nov;54(9):7520-7533. doi: 10.1007/s12035-016-0257-9. Epub 2016 Nov 8.
5
Clinical and diagnostic features of patients with familial multiple sclerosis.家族性多发性硬化症患者的临床和诊断特征。
Med Hypotheses. 2019 Oct;131:109310. doi: 10.1016/j.mehy.2019.109310. Epub 2019 Jul 13.
6
Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.脑脊液中细胞外线粒体葡萄糖代谢增加的证据表明线粒体功能障碍与多发性硬化症疾病进展有关。
J Neurol Sci. 2008 Dec 15;275(1-2):106-12. doi: 10.1016/j.jns.2008.07.032. Epub 2008 Sep 9.
7
Serum NSE level and disability progression in multiple sclerosis.血清神经元特异性烯醇化酶水平与多发性硬化症的残疾进展
J Neurol Sci. 2015 Mar 15;350(1-2):46-50. doi: 10.1016/j.jns.2015.02.009. Epub 2015 Feb 11.
8
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.多发性硬化早期轴突损伤的证据及其与残疾的相关性。
Arch Neurol. 2001 Jan;58(1):65-70. doi: 10.1001/archneur.58.1.65.
9
N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.N-乙酰天门冬氨酸和神经丝作为进展型多发性硬化症患者轴突损伤的生物标志物。
J Neurol. 2014 Dec;261(12):2338-43. doi: 10.1007/s00415-014-7507-4. Epub 2014 Sep 17.
10
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.灰质萎缩与通过多发性硬化功能复合量表(MSFC)而非扩展残疾状态量表(EDSS)测量的多发性硬化症残疾进展相关。
J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19.

引用本文的文献

1
Correlation of the intestinal flora and its metabolites with the colonic transport function in functional constipation.功能性便秘中肠道菌群及其代谢产物与结肠传输功能的相关性
Front Microbiol. 2025 May 21;16:1591697. doi: 10.3389/fmicb.2025.1591697. eCollection 2025.
2
Bidirectional mendelian randomization assessment of causality between lactate levels and multiple autoimmune diseases.乳酸水平与多种自身免疫性疾病之间因果关系的双向孟德尔随机化评估
Sci Rep. 2025 May 21;15(1):17700. doi: 10.1038/s41598-025-02507-9.
3
Relationship between preoperative high arterial blood lactate level and delirium after deep brain stimulation surgery in Parkinson's disease.
帕金森病患者脑深部电刺激术后术前高动脉血乳酸水平与谵妄的关系。
Front Aging. 2025 Mar 25;6:1538012. doi: 10.3389/fragi.2025.1538012. eCollection 2025.
4
A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications.缺氧-炎症循环与多发性硬化症:机制及治疗意义
Curr Treat Options Neurol. 2025;27(1):6. doi: 10.1007/s11940-024-00816-4. Epub 2024 Nov 18.
5
Oral and gut microbial profiling in periodontitis and Parkinson's disease.牙周炎与帕金森病的口腔和肠道微生物谱分析
J Oral Microbiol. 2024 Mar 21;16(1):2331264. doi: 10.1080/20002297.2024.2331264. eCollection 2024.
6
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.那他珠单抗促进多发性硬化症的抗炎和修复作用。
PLoS One. 2024 Mar 25;19(3):e0300914. doi: 10.1371/journal.pone.0300914. eCollection 2024.
7
Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis.多发性硬化症外周免疫细胞的线粒体和代谢功能障碍。
J Neuroinflammation. 2024 Jan 20;21(1):28. doi: 10.1186/s12974-024-03016-8.
8
Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis.线粒体功能障碍在多发性硬化症进展中的意义。
Int J Mol Sci. 2022 Oct 22;23(21):12725. doi: 10.3390/ijms232112725.
9
Biochemical Discrimination of the Down Syndrome-Related Metabolic and Oxidative/Nitrosative Stress Alterations from the Physiologic Age-Related Changes through the Targeted Metabolomic Analysis of Serum.通过血清靶向代谢组学分析对唐氏综合征相关代谢及氧化/亚硝化应激改变与生理性年龄相关变化进行生化鉴别。
Antioxidants (Basel). 2022 Jun 20;11(6):1208. doi: 10.3390/antiox11061208.
10
Gut Microbiome in Progressive Multiple Sclerosis.进展性多发性硬化症中的肠道微生物组。
Ann Neurol. 2021 Jun;89(6):1195-1211. doi: 10.1002/ana.26084. Epub 2021 Apr 30.